#China #Shanghai #pharmaceuticals #CPHI #PMEC China

The CPHI & PMEC China 2025: A Gateway to Global Opportunities

The CPHI & PMEC China exhibition, scheduled from June 24 to 26, is gearing up to become the largest pharmaceutical event ever held in Asia, showcasing a revival in the global pharmaceutical market. Taking place at the New International Expo Center in Shanghai, this year’s edition anticipates over 90,000 attendees, including more than 12,000 representatives from international companies, marking a significant rise in global engagement.

The surge in international interest is attributed to an easing of trade barriers and favorable pricing trends within the pharmaceutical sector. Attendees will include a record number of representatives seeking to forge new supplier relationships in China's robust manufacturing ecosystem for active pharmaceutical ingredients and production equipment.

Notably, Western pharmaceutical firms are increasingly looking towards Chinese biotechnological assets, seeking not only access to the domestic market but also global licensing opportunities. Additionally, Middle Eastern countries are ramping up participation as they establish regional manufacturing centers, while India and the United States will also have a stronger presence this year.

Strong Foundations of the Pharmaceutical Sector

According to Natasha Jennings, Global Marketing Director of Growth, the fundamental aspects of the pharmaceutical industry remain strong. "The global pharmaceutical sector is reaching record goals in drug discovery and is returning to a phase of growth," she stated. The engagement level at CPHI & PMEC China is substantial, with 80% of international participants possessing purchasing authority and over 50% holding senior management positions. This high level of decision-making involvement highlights the strategic importance of the event.

Accompanying events will enhance the experience for participants, including a program for natural extracts buyers on June 23 and a pharmaceutical machinery buyer program on June 24 and 25. The exhibition will also feature the CPHI Celebration Awards, a specialized conference including the 10th Biopharmaceuticals Outlook Summit, innovation showcases, and factory visits across the region.

Covering over 230,000 square meters with 3,500 exhibitors from 150 countries, the event creates twelve specialized zones, including newly added sections for BioTech and Fluid Precision Equipment. Jennings emphasizes that global managers are keen on expanding their partnership networks within China to secure primary, secondary, and backup suppliers for long-term strategic planning.

A Resurgence of Global Pharmaceutical Partnerships

With the improved business relationships, there is a renaissance in global pharmaceutical collaborations. This event not only reflects the ongoing maturation of the sector but also serves as a launchpad for future innovative solutions that can address global health challenges.

For those interested in participating, registration is available on the official CPHI & PMEC China website. Media inquiries can be directed to Winnie Xu at the provided contact details. As the pharmaceutical industry aims to bolster its infrastructure, CPHI & PMEC China stands as a pivotal gathering for fostering relationships and exploring new avenues in the sector.